TGTrevor J. Gould

Trevor J. Gould

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Trevor J. Gould has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Aviti Sequencing and Marker Gene Data Analysis

    by Trevor J Gould, Madeline Taylor, Cara Santelli

    Accurate identification of microbial species in complex populations and communities relies on the isolation of representative marker 16S, ITS, and 18S sequences through the use of DNA extraction, PCR, and sequencing. Aviti sequencing has brought an improvement in the read quality and depth of marker gene sequencing technology. Quality scores exceeding Q40 representing highly accurate sequencing allows researchers to ask more questions of their marker gene data. However, this improvement in quality and throughput also brings with it a surprising increase in diversity of amplicon sequencing variants (ASVs) making further analysis and comparisons to previous studies on Illumina platforms challenging. This increased diversity causes downstream processing issues, including an over-reporting of chimeric ASVs. Here we identify this problem and put forward straightforward solutions to retain counts and reduce technically introduced diversity, as well as tying chimeric read identification to minimum parent distance. Through the use of synthetic mock samples, we discovered that erroneous ASVs are systematically substitution errors introduced by the upstream PCR methods. This error can be reduced significantly bioinformatically through clustering of ASVs within 99% similarity. Further we highlight technically introduced variation as a result of variable region length, sample misassignment, and sample biomass. Collectively, these results improve the similarity of Aviti and Illumina datasets for better comparisons of microbial studies from different platforms.

  • Open Access

    Effects of Caprylic Acid on the Cecal Colonization of Multidrug-Resistant Salmonella Heidelberg and the Cecal Microbiome in Broiler Chickens

    by Shijinaraj Manjankattil, Dhananjai Muringattu Prabhakaran, Anup Kollanoor Johny, Claire Peichel, Divek V. T. Nair, Grace Dewi, Jason Langlie, Trevor J. Gould, Annie M. Donoghue

    This study determined the efficacy of in-feed supplementation of a medium-chain fatty acid, caprylic acid (CA), on the cecal colonization of multidrug-resistant (MDR) Salmonella Heidelberg (SH) and its effect on the cecal microbiome of commercial broilers. A total of 24, 4-week-old commercial Ross 708 chickens were randomly allocated to two replicates of four treatment groups in eight BSL2 isolators (3 birds/isolator): Negative control (NC), Positive Control (PC), Antibiotic group (AB), and caprylic acid (CA) groups. The birds received a Salmonella-free standard corn–soy-based diet, with the broilers in the AB receiving 50 g/ton bacitracin methylene disalicylate, and the CA group receiving caprylic acid (1% w/w), in feed from days 1 to 35. All birds, except those in the NC group, were challenged with ~3.7 log10 CFU of MDR SH/5 mL by crop gavage on day 29. Cecal samples were collected 7 days after the challenge for SH recovery by direct plating and enrichment, as well as for DNA extraction for 16S rRNA gene amplicon sequencing. Compared to the PC group, a 3.6 log10 CFU/g reduction in SH was observed in the CA group (p < 0.05). Although no significant effect of CA on cecal microbial composition was observed, a significant difference in taxonomic α- and β-diversities was observed in the AB. CA also resulted in significant differences in hub taxa compared to PC in the network association analysis, indicating a potential role for microbiome modulation in its mechanism of action.


  • Open Access

    Broad-Spectrum Antibacterial Activity of Antioxidant Octyl Gallate and Its Impact on Gut Microbiome

    by Junshu Yang, Trevor J. Gould, Byeonghwa Jeon, Yinduo Ji

    In this study, we investigated the antibacterial activity of octyl gallate (OG), an antioxidant food additive, against both Gram-positive and Gram-negative bacterial pathogens. OG demonstrated robust bactericidal activity against Gram-positive bacterial pathogens with minimum inhibitory concentrations (MIC) of 4 to 8 µg/mL and minimum bactericidal concentrations (MBC) of 8 to 16 µg/mL in vitro. However, OG exhibited limited antibacterial activity against Gram-negative bacteria, including E. coli, although it could inhibit bacterial growth in vitro. Importantly, OG administration in mice altered the fecal microbiome, significantly reducing microbial diversity, modifying community structure, and increasing the abundance of beneficial bacteria. Additionally, OG displayed low cytotoxicity and hemolytic activity. These findings suggest that OG could be developed as a novel antibacterial agent, particularly against multi-drug-resistant MRSA. Our results provide new insights into the therapeutic potential of OG in modulating the gut microbiome, especially in conditions associated with microbial imbalance, while ensuring food safety.


  • Open Access

    Chronic obstructive pulmonary disease upper airway microbiota alpha diversity is associated with exacerbation phenotype: a case-control observational study

    by Alexa A. Pragman, Katherine A. Knutson, Trevor J. Gould, Richard E. Isaacson, Cavan S. Reilly, Chris H. Wendt

    Chronic obstructive pulmonary disease (COPD) frequent exacerbators (FE) suffer increased morbidity and mortality compared to infrequent exacerbators (IE). The association between the oral and sputum microbiota and exacerbation phenotype is not well defined. The objective of this study was to determine key features that differentiate the oral and sputum microbiota of FEs from the microbiota of IEs during periods of clinical stability. We recruited 11 FE and 11 IE who had not used antibiotics or systemic corticosteroids in the last 1 month. Subjects provided oral wash and sputum samples, which underwent 16S V4 MiSeq sequencing and qPCR of 16S rRNA. Data were analyzed using Dada2 and R. FE and IE were similar in terms of age, FEV1 percent predicted (FEV1pp), pack-years of tobacco exposure, and St. George’s Respiratory Questionnaire score. 16S copy numbers were significantly greater in sputum vs. oral wash (p = 0.01), but phenotype was not associated with copy number. Shannon diversity was significantly greater in oral samples compared to sputum (p = 0.001), and IE samples were more diverse than FE samples (p < 0.001). Sputum samples from FE had more Haemophilus and Moraxella compared to IE sputum samples, due to dominance of these COPD-associated taxa in three FE sputum samples. Amplicon sequencing variant (ASV)-level analysis of sputum samples revealed one ASV (Actinomyces) was significantly more abundant in IE vs. FE sputum (padj = 0.048, Wilcoxon rank-sum test), and this persisted after controlling for FEV1pp. Principal coordinate analysis using Bray-Curtis distance with PERMANOVA analyses demonstrated clustering by anatomic site, phenotype, inhaled corticosteroid use, current tobacco use, COPD severity, and last professional dental cleaning. FE have less diverse oral and sputum microbiota than IE. Actinomyces was significantly more abundant in IE sputum than FE sputum. The oral and sputum microbiota of COPD subjects cluster based on multiple clinical factors, including exacerbation phenotype. Even during periods of clinical stability, the frequent exacerbator phenotype is associated with decreased alpha diversity, beta-diversity clustering, and changes in taxonomic abundance.


  • Open Access

    Impact of Agaricus bisporus Mushroom Consumption on Gut Health Markers in Healthy Adults

    by Julie Hess, Qi Wang, Trevor Gould, Joanne Slavin

    Eating Agaricus bisporus mushrooms may impact gut health, because they contain known prebiotics. This study assessed mushroom consumption compared to meat on gastrointestinal tolerance, short chain fatty acid (SCFA) production, laxation, and fecal microbiota. A randomized open-label crossover study was conducted in healthy adults (n = 32) consuming protein-matched amounts of mushrooms or meat twice daily for ten days. Breath hydrogen measures were taken on day one, and gastrointestinal tolerance was evaluated throughout treatments. Fecal sample collection was completed days 6–10, and samples were assessed for bacterial composition, SCFA concentrations, weight, pH, and consistency. There were no differences in breath hydrogen, stool frequency, consistency, fecal pH, or SCFA concentrations between the two diets. The mushroom diet led to greater overall gastrointestinal symptoms than the meat diet on days one and two. The mushroom-rich diet resulted in higher average stool weight (p = 0.002) and a different fecal microbiota composition compared to the meat diet, with greater abundance of Bacteroidetes (p = 0.0002) and lower abundance of Firmicutes (p = 0.0009). The increase in stool weight and presence of undigested mushrooms in stool suggests that mushroom consumption may impact laxation in healthy adults. Additional research is needed to interpret the health implications of fecal microbiota shifts with mushroom feeding.


  • Open Access

    Prebiotic Dietary Fiber and Gut Health: Comparing the in Vitro Fermentations of Beta-Glucan, Inulin and Xylooligosaccharide

    by Justin L. Carlson, Jennifer M. Erickson, Julie M. Hess, Trevor J. Gould, Joanne L. Slavin

    Prebiotic dietary fiber supplements are commonly consumed to help meet fiber recommendations and improve gastrointestinal health by stimulating beneficial bacteria and the production of short-chain fatty acids (SCFAs), molecules beneficial to host health. The objective of this research project was to compare potential prebiotic effects and fermentability of five commonly consumed fibers using an in vitro fermentation system measuring changes in fecal microbiota, total gas production and formation of common SCFAs. Fecal donations were collected from three healthy volunteers. Materials analyzed included: pure beta-glucan, Oatwell (commercially available oat-bran containing 22% oat β-glucan), xylooligosaccharides (XOS), WholeFiber (dried chicory root containing inulin, pectin, and hemi/celluloses), and pure inulin. Oatwell had the highest production of propionate at 12 h (4.76 μmol/mL) compared to inulin, WholeFiber and XOS samples (p < 0.03). Oatwell’s effect was similar to those of the pure beta-glucan samples, both samples promoted the highest mean propionate production at 24 h. XOS resulted in a significant increase in the genus Bifidobacterium after 24 h of fermentation (0 h:0.67 OTUs (operational taxonomic unit); 24 h:5.22 OTUs; p = 0.038). Inulin and WholeFiber increased the beneficial genus Collinsella, consistent with findings in clinical studies. All analyzed compounds were fermentable and promoted the formation of beneficial SCFAs.


  • Open Access

    Gut microbiota has a widespread and modifiable effect on host gene regulation

    by Allison L Richards, Amanda L. Muehlbauer, Adnan Alazizi, Michael B. Burns, Anthony Findley, Francesco Messina, Trevor J. Gould, Camilla Cascardo, Roger Pique-Regi, Ran Blekhman, et al.

    Variation in gut microbiome is associated with wellness and disease in humans, yet the molecular mechanisms by which this variation affects the host are not well understood. A likely mechanism is through changing gene regulation in interfacing host epithelial cells. Here, we treated colonic epithelial cells with live microbiota from five healthy individuals and quantified induced changes in transcriptional regulation and chromatin accessibility in host cells. We identified over 5,000 host genes that change expression, including 588 distinct associations between specific taxa and host genes. The taxa with the strongest influence on gene expression alter the response of genes associated with complex traits. Using ATAC-seq, we show that a subset of these changes in gene expression are likely the result of changes in host chromatin accessibility and transcription factor binding induced by exposure to gut microbiota. We then created a manipulated microbial community with titrated doses of Collinsella , demonstrating that both natural and controlled microbiome composition leads to distinct, and predictable, gene expression profiles in host cells. Together, our results suggest that specific microbes play an important role in regulating expression of individual host genes involved in human complex traits. The ability to fine tune the expression of host genes by manipulating the microbiome suggests future therapeutic routes.